EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The genomic afterlife of cancer therapy

Xiaolu Wang, Nilay S Sethi

Journal of Clinical Investigation · 02.11.2026 · 136 (21)

DOI: 10.1172/jci213544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.11.2026. Verfasst von Xiaolu Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
  • Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Wang, X., & Sethi, N. S. (2026). The genomic afterlife of cancer therapy. Journal of Clinical Investigation, 136(21). https://doi.org/10.1172/jci213544

Vancouver

Wang X, Sethi NS. The genomic afterlife of cancer therapy. Journal of Clinical Investigation. 2026;136(21). doi:10.1172/jci213544

BibTeX
@article{Wang2026,
  author = {Wang, Xiaolu and Sethi, Nilay S},
  title = {The genomic afterlife of cancer therapy},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {21},
  doi = {10.1172/jci213544}
}
Kostenlos starten →